1.Date of the shareholders' meeting:2024/04/12

2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgment of the 2023 deficit compensation

3.Important resolutions II.Amendments of the company charter:Approval of amendments to the Company's Articles of Incorporation

4.Important resolutions III.Business report and financial statements:Acknowledgment of the 2023 business report and financial statements

5.Important resolutions IV.Election for directors and supervisors:
Completion of early re-election of directors and supervisors.
The list of person elected is as below:
Directors:
Representative of TSH Biopharm Corporation Limited: Sze-Yuan Yang
Representative of TSH Biopharm Corporation Limited: Carl Hsiao
Jing-Ping Liou
Supervisor:
Representative of TTY BIOPHARM COMPANY LIMITED: Kuo-Chiang Chang

6.Important resolutions V.Other matters:Approval of the release of non-competition restrictions on new directors and its representatives.

7.Any other matters that need to be specified:None